ES469878A1 - Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas - Google Patents
Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogasInfo
- Publication number
- ES469878A1 ES469878A1 ES469878A ES469878A ES469878A1 ES 469878 A1 ES469878 A1 ES 469878A1 ES 469878 A ES469878 A ES 469878A ES 469878 A ES469878 A ES 469878A ES 469878 A1 ES469878 A1 ES 469878A1
- Authority
- ES
- Spain
- Prior art keywords
- tyrosine
- alpha
- methyl
- para
- drug addiction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Un procedimiento para preparar una composición farmacéutica para el tratamiento del hábito de consumir drogas sin experimentar cristaluria, que comprende asociar una cantidad predeterminada terapéuticamente eficaz de alfa-metil-tirosina de la fórmula estructural **(Fórmula)** Y un agente alcalinizante en una cantidad suficiente para que, a la dosis administrada, provoque que la orina del paciente tenga un pH alcalino, preferiblemente superior a 7,4 y seguidamente llevar la composición obtenida a una forma de administración adecuada, tal como píldora, cápsula, solución para inyección y otras.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/797,372 US4117161A (en) | 1977-05-16 | 1977-05-16 | Method of pharmacologically treating drug addiction with alpha-methyl-para-tyrosine |
Publications (1)
Publication Number | Publication Date |
---|---|
ES469878A1 true ES469878A1 (es) | 1979-09-16 |
Family
ID=25170655
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES469878A Expired ES469878A1 (es) | 1977-05-16 | 1978-05-16 | Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas |
Country Status (5)
Country | Link |
---|---|
US (1) | US4117161A (es) |
JP (1) | JPS53142535A (es) |
CA (1) | CA1091155A (es) |
ES (1) | ES469878A1 (es) |
IT (1) | IT1104177B (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5051426A (en) * | 1990-03-27 | 1991-09-24 | Parnell Pharmaceuticals, Inc. | Method for effecting withdrawal from drug dependency |
US5219858A (en) * | 1990-03-27 | 1993-06-15 | Parnell Pharmaceuticals, Inc. | Method and compositions for effecting withdrawal from drug dependency |
US20040167164A1 (en) * | 1998-05-05 | 2004-08-26 | Jose Pozuelo | Compositions and methods for treating particular chemical addictions and mental illnesses |
US20030049272A1 (en) * | 2001-08-30 | 2003-03-13 | Yatindra Joshi | Pharmaceutical composition which produces irritation |
RU2209062C1 (ru) * | 2002-03-19 | 2003-07-27 | Институт физиологии им. И.П.Павлова РАН | Вещество, обладающее седативным действием |
US10646552B2 (en) | 2012-01-17 | 2020-05-12 | Tyme, Inc. | Pharmaceutical compositions and methods |
US10272068B2 (en) | 2012-01-17 | 2019-04-30 | Tyme, Inc. | Pharmaceutical compositions and methods |
US20130183263A1 (en) | 2012-01-17 | 2013-07-18 | Steven Hoffman | Pharmaceutical compositions and methods |
US8481498B1 (en) | 2012-01-17 | 2013-07-09 | Steven Hoffman | Pharmaceutical compositions and methods |
US10813901B2 (en) | 2013-10-22 | 2020-10-27 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
US9326962B2 (en) | 2013-10-22 | 2016-05-03 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
US9763903B2 (en) | 2013-10-22 | 2017-09-19 | Steven Hoffman | Compositions and methods for treating intestinal hyperpermeability |
US10751313B2 (en) | 2013-10-22 | 2020-08-25 | Yamo Pharmaceuticals Llc | Compositions and methods for treating autism |
US9585841B2 (en) | 2013-10-22 | 2017-03-07 | Tyme, Inc. | Tyrosine derivatives and compositions comprising them |
US11806326B2 (en) | 2018-01-29 | 2023-11-07 | Jonathan Sackner-Bernstein | Methods for dopamine modulation in human neurologic diseases |
RU2719575C1 (ru) * | 2019-02-01 | 2020-04-21 | Общество с ограниченной ответственностью "Центр ранней диагностики нейродегенеративных заболеваний (НДЗ)" | Фармацевтическая композиция на основе альфа-метил-п-тирозина и способ ранней диагностики болезни Паркинсона |
KR20220098682A (ko) | 2019-05-14 | 2022-07-12 | 타임, 인크. | 암을 치료하기 위한 조성물 및 방법 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2682871A (en) * | 1970-03-24 | 1972-09-28 | Sandler Merton | Pharmaceutical compositions |
-
1977
- 1977-05-16 US US05/797,372 patent/US4117161A/en not_active Expired - Lifetime
-
1978
- 1978-05-11 CA CA303,280A patent/CA1091155A/en not_active Expired
- 1978-05-15 IT IT49358/78A patent/IT1104177B/it active
- 1978-05-16 ES ES469878A patent/ES469878A1/es not_active Expired
- 1978-05-16 JP JP5816078A patent/JPS53142535A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
JPS53142535A (en) | 1978-12-12 |
IT7849358A0 (it) | 1978-05-15 |
CA1091155A (en) | 1980-12-09 |
US4117161A (en) | 1978-09-26 |
IT1104177B (it) | 1985-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES469878A1 (es) | Un procedimiento para preparar una composicion farmaceutica para el tratamiento del habito de consumir drogas | |
ES2089027T3 (es) | Forma de dosificacion transmucosica. | |
IL99699A0 (en) | Method of treating or preventing type 1 diabetes by oral administration of insulin | |
DE69230112D1 (de) | Fortschrittliches arzneistoffabgabesystem und verfahren zur behandlung von psychiatrischen, neurologischen und anderen erkrankungen mit carbamazepin | |
ATE94393T1 (de) | Dosisform zur oralen verabreichung des hypoglykaemischen glipizids. | |
ATE5852T1 (de) | Therapeutische zusammensetzungen mit gesteigerter bioverfuegbarkeit und verfahren zu deren herstellung. | |
FI95653C (fi) | Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi | |
JPS6463522A (en) | Pharmaceutical composition for treating and preventing gallstone and gall deficient indigestion | |
KR890006227A (ko) | 페놀-함유 진해성 액체 조성물 | |
ES449797A1 (es) | Un procedimiento para preparar derivados de 1,3,8-tiazaspiro4,5 deon-4-ona. | |
MY100780A (en) | Azumolene dosage form. | |
US3873709A (en) | Method of treating psychosis | |
DE3344086A1 (de) | Verwendung von azaspirogermanium-verbindungen zur behandlung von arthritis | |
WO2001049269A1 (en) | Sustained-releasing anthelmintic compositions comprising praziquantel | |
KR930702985A (ko) | 식도암의 치료 | |
US3885030A (en) | Medicine comprising lysine by-products | |
KR930702984A (ko) | 비-소세포 폐암의 치료 | |
OA09379A (fr) | Polyméthylène-imines disubstituées, leur procédé de préparation et les compositions pharmaceutiques les contenant. | |
GB2019720A (en) | S-adenosyl-L-homocysteine and salts thereof for use in therapy | |
SU1156682A1 (ru) | Способ лечени хал зиона | |
SU980720A1 (ru) | Способ лечени больных лепрой | |
SU718106A1 (ru) | Способ лечени туберкулеза легких по а.с.орешкину | |
JPS5569510A (en) | Carcinostatic agent | |
SU938947A1 (ru) | Способ определени терапевтических доз лекарственного препарата | |
AP105A (en) | Treatment of animals. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD1A | Patent lapsed |
Effective date: 19980302 |